Results 41 to 50 of about 1,050,605 (265)

Improving an anti-beta2 GPI ELISA by reducing the influence of a blocking agent [PDF]

open access: yesArthritis Research & Therapy, 2001
There are still considerable interlaboratory differences in positivity rate in anti-β2GPI ELISA. We have already shown that BSA as ablocking agent could introduce a substantial interference effect in an anti-β2GPI ELISA. The aim of this study was to validate and possibly reduce an interference effect of different blocking agents on the detection of ...
Ambrozic, A   +3 more
openaire   +1 more source

Development of a Blocking ELISA for Screening Antibodies to Porcine Rubulavirus, La Piedad Michoacan Virus

open access: yes, 1999
A blocking enzyme-linked immunosorbent assay (ELISA) was developed to detect antibodies to porcine rubulavirus (La Piedad Michoacan Virus [LPMV]) in serum samples from pigs.
J. Moreno-Lopez   +7 more
core   +1 more source

Direct replacement of antibodies with molecularly imprinted polymer (MIP) nanoparticles in ELISA - development of a novel assay for vancomycin [PDF]

open access: yes, 2013
A simple and straightforward technique for coating microplate wells with molecularly imprinted polymer nanoparticles (nanoMIPs) to develop ELISA type assays is presented here for the first time.
Guerreiro, Antonio R.   +7 more
core   +1 more source

Optimisation of indirect elisa by comparison of different antigen preparations for detection of antibodies against schmallenberg virus [PDF]

open access: yesKafkas Universitesi Veteriner Fakültesi Dergisi, 2020
Schmallenberg virus (SBV) infection, discovered in 2011, was reported in Europe including Turkey, Africa and recently in some Asian countries.
Ahmet Kursat AZKUR   +3 more
doaj   +1 more source

Neutralization of the PTX3/CD44 axis suppresses TGF‐β1 signaling in kidney fibrosis

open access: yesFEBS Letters, EarlyView.
This study investigates how the PTX3/CD44 axis promotes kidney fibrosis by activating TGF‐β1 signaling. We demonstrate that the neutralizing antibody WHC‐001 effectively inhibits this pathway, suppressing myofibroblast activation and partial epithelial–mesenchymal transition (EMT).
Chao‐Chun Cheng   +8 more
wiley   +1 more source

ELISA

open access: yes, 2022
 origin data of ELISA 
Lai Jiang (12959588)
core   +2 more sources

Solid‐phase extraction treatment is required for measurement of active glucagon‐like peptide‐1 by enzyme‐linked immunosorbent assay kit affected by heterophilic antibodies

open access: yesJournal of Diabetes Investigation, 2019
Aims/Introduction It is reported that interfering substances in the blood might influence the value for measurement of active glucagon‐like peptide‐1 (GLP‐1) in human plasma.
Tomonori Hasegawa   +5 more
doaj   +1 more source

Identification and elimination of false-positives in an ELISA-based system for qualitative assessment of glycoconjugate binding using a selection of plant lectins

open access: yesBioTechniques, 2007
Systematic optimization of a lectin-based enzyme-linked immunosorbent assay (ELISA) procedure using a panel of 21 biotinylated plant lectins and a glycoprotein with defined glycosylation (i) identified blocking as a limiting step in solid phase sugar ...
Babak Afrough   +2 more
doaj   +1 more source

Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy

open access: yesFEBS Letters, EarlyView.
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley   +1 more source

The use of an indirect ELISA with protein G-peroxidase conjugate and a blocking ELISA to demonstrate recent bluetongue infection in sheep

open access: yesJournal of Virological Methods, 1994
The humoral immune response of sheep infected with bluetongue virus serotypes 3, 9 and 16 was monitored by plaque inhibition (PI), blocking ELISA (BELISA) and indirect ELISA over a period of 63 days post-infection. Results indicated that testing of a single plasma or serum sample by both a BELISA and an indirect ELISA using a recombinant streptococcal ...
Lunt, R, Blacksell, S, Newberry, K
openaire   +3 more sources

Home - About - Disclaimer - Privacy